These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 34792685)

  • 1. The role of the immune system in idiopathic nephrotic syndrome.
    Hackl A; Zed SEDA; Diefenhardt P; Binz-Lotter J; Ehren R; Weber LT
    Mol Cell Pediatr; 2021 Nov; 8(1):18. PubMed ID: 34792685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The immunopathogenesis of idiopathic nephrotic syndrome: a narrative review of the literature.
    Kitsou K; Askiti V; Mitsioni A; Spoulou V
    Eur J Pediatr; 2022 Apr; 181(4):1395-1404. PubMed ID: 35098401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenesis of minimal change nephrotic syndrome: an immunological concept.
    Kim SH; Park SJ; Han KH; Kronbichler A; Saleem MA; Oh J; Lim BJ; Shin JI
    Korean J Pediatr; 2016 May; 59(5):205-11. PubMed ID: 27279884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunology of idiopathic nephrotic syndrome.
    Colucci M; Corpetti G; Emma F; Vivarelli M
    Pediatr Nephrol; 2018 Apr; 33(4):573-584. PubMed ID: 28451893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Idiopathic Nephrotic Syndrome in Pediatrics: An Up-to-date.
    da Silva Filha R; Burini K; Pires LG; Brant Pinheiro SV; Simões E Silva AC
    Curr Pediatr Rev; 2022; 18(4):251-264. PubMed ID: 35289253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B cell phenotype, activity, and function in idiopathic nephrotic syndrome.
    Liu J; Guan F
    Pediatr Res; 2023 Jun; 93(7):1828-1836. PubMed ID: 36316536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of nephrotic syndrome: immuno- or rather podocyte therapy?].
    Lewko B
    Postepy Hig Med Dosw (Online); 2016 May; 70():459-70. PubMed ID: 27180964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failure of regulation results in an amplified oxidation burst by neutrophils in children with primary nephrotic syndrome.
    Bertelli R; Trivelli A; Magnasco A; Cioni M; Bodria M; Carrea A; Montobbio G; Barbano G; Ghiggeri GM
    Clin Exp Immunol; 2010 Jul; 161(1):151-8. PubMed ID: 20491793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunopathogenesis of idiopathic nephrotic syndrome with relapse.
    Sahali D; Sendeyo K; Mangier M; Audard V; Zhang SY; Lang P; Ollero M; Pawlak A
    Semin Immunopathol; 2014 Jul; 36(4):421-9. PubMed ID: 24402710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Podocyte sphingomyelin phosphodiesterase acid-like 3b decreases among children with idiopathic nephrotic syndrome.
    Watanabe S; Hirono K; Aizawa T; Tsugawa K; Joh K; Imaizumi T; Tanaka H
    Clin Exp Nephrol; 2021 Jan; 25(1):44-51. PubMed ID: 32946006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glomerular filtration barrier dysfunction in a self-limiting, RNA virus-induced glomerulopathy resembles findings in idiopathic nephrotic syndromes.
    Nusshag C; Stütz A; Hägele S; Speer C; Kälble F; Eckert C; Brenner T; Weigand MA; Morath C; Reiser J; Zeier M; Krautkrämer E
    Sci Rep; 2020 Nov; 10(1):19117. PubMed ID: 33154421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Idiopathic nephrotic syndrome and serum permeability factors: a molecular jigsaw puzzle.
    Candelier JJ; Lorenzo HK
    Cell Tissue Res; 2020 Feb; 379(2):231-243. PubMed ID: 31848752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rituximab in idiopathic nephrotic syndrome: does it make sense?
    Cara-Fuentes G; Kairalla JA; Ishimoto T; Rivard C; Johnson RJ; Garin EH
    Pediatr Nephrol; 2014 Aug; 29(8):1313-9. PubMed ID: 23793923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of idiopathic nephrotic syndrome in children].
    Velásquez Jones L
    Bol Med Hosp Infant Mex; 2014; 71(5):315-322. PubMed ID: 29421622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of the immune system in idiopathic nephrotic syndrome: a review of clinical and experimental studies.
    Pereira Wde F; Brito-Melo GE; Guimarães FT; Carvalho TG; Mateo EC; Simões e Silva AC
    Inflamm Res; 2014 Jan; 63(1):1-12. PubMed ID: 24121975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular stratification of idiopathic nephrotic syndrome.
    Saleem MA
    Nat Rev Nephrol; 2019 Dec; 15(12):750-765. PubMed ID: 31654044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-CD20 Antibodies for Idiopathic Nephrotic Syndrome in Children.
    Ravani P; Bonanni A; Rossi R; Caridi G; Ghiggeri GM
    Clin J Am Soc Nephrol; 2016 Apr; 11(4):710-20. PubMed ID: 26585985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of Interleukin-15 (IL-15) Concentration in Children with Idiopathic Nephrotic Syndrome.
    Badeński A; Badeńska M; Świętochowska E; Janek A; Gliwińska A; Morawiec-Knysak A; Szczepańska M
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Cytokines in Nephrotic Syndrome.
    Ahmadian E; Rahbar Saadat Y; Dalir Abdolahinia E; Bastami M; Shoja MM; Zununi Vahed S; Ardalan M
    Mediators Inflamm; 2022; 2022():6499668. PubMed ID: 35185384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B-Cell Dysregulation in Idiopathic Nephrotic Syndrome: What We Know and What We Need to Discover.
    Colucci M; Oniszczuk J; Vivarelli M; Audard V
    Front Immunol; 2022; 13():823204. PubMed ID: 35140723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.